Skip to content

Clinical trials

Recruiting Respiratory Distress Syndrome trials in China

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Respiratory Distress Syndrome Status: Recruiting Country / region: China Clear all

34 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20171
20211
20222
20237
20246
20259
20268

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Recruiting34

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Southeast University, China7
Beijing Chao Yang Hospital2
Daping Hospital and the Research Institute of Surgery of the Third Military Medical University2
Zhongda Hospital2
Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA)1
AstraZeneca1
Beijing Anzhen Hospital1
Beijing Tsinghua Chang Gung Hospital1
Bin Du1
Changchun Tuohua Pharmaceutical Co., Ltd.1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Respiratory Distress Syndrome34
Acute Lung Injury3
Sepsis3
Premature Birth2
Pulmonary Atelectasis2
Respiratory Aspiration2
Ventilator-Induced Lung Injury2
Acute Kidney Injury1
Bronchial Spasm1
COVID-191

Trials

Showing 1 to 25 of 34. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.